{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:38:57Z","timestamp":1792273137010,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Carbohydrate Polymers"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.carbpol.2023.120717","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T12:02:21Z","timestamp":1676635341000},"page":"120717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Cyclodextrin-enabled nepafenac eye drops with improved absorption open a new therapeutic window"],"prefix":"10.1016","volume":"310","author":[{"given":"Anna","family":"Vincze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9ka","family":"Facsk\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ria","family":"Budai-Sz\u0171cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Katona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benj\u00e1min","family":"Gyarmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Csorba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rom\u00e1na","family":"Zelk\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n Zsolt","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lajos","family":"Szente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy T.","family":"Balogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.carbpol.2023.120717_bb0005","article-title":"Physicochemical properties of hyaluronic acid\u2013based lubricant eye drops","volume":"8","author":"Aragona","year":"2019","journal-title":"Translational visionScience and Technology"},{"issue":"6","key":"10.1016\/j.carbpol.2023.120717_bb0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.8.6.2","article-title":"Physicochemical properties of hyaluronic acid-based lubricant eye drops","volume":"8","author":"Aragona","year":"2019","journal-title":"Translational Vision Science & Technology"},{"key":"10.1016\/j.carbpol.2023.120717_bb0015","series-title":"Absorption and drug development","first-page":"12","article-title":"Permeability-solubility-charge state and pH-partition hypothesis","author":"Avdeef","year":"2012"},{"key":"10.1016\/j.carbpol.2023.120717_bb0020","series-title":"Absorption and drug development","first-page":"465","article-title":"Permeability equations","author":"Avdeef","year":"2012"},{"key":"10.1016\/j.carbpol.2023.120717_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120364","article-title":"A polymeric aqueous tacrolimus formulation for topical ocular delivery","volume":"599","author":"Badr","year":"2021","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.carbpol.2023.120717_bb0030","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1155\/2014\/861904","article-title":"Ophthalmic drug dosage forms: Characterisation and research methods","volume":"2014","author":"Baranowski","year":"2014","journal-title":"The Scientific World Journal"},{"issue":"5","key":"10.1016\/j.carbpol.2023.120717_bb0035","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/17425247.5.5.567","article-title":"Ocular novel drug delivery: Impacts of membranes and barriers","volume":"5","author":"Barar","year":"2008","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.carbpol.2023.120717_bb0040","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2147\/DDDT.S264745","article-title":"New approach in ocular drug delivery: In vitro and ex vivo investigation of cyclodextrin-containing, mucoadhesive eye drop formulations","volume":"15","author":"B\u00edr\u00f3","year":"2021","journal-title":"Drug Design, Development and Therapy"},{"key":"10.1016\/j.carbpol.2023.120717_bb0045","article-title":"Gel formulations for treatment of the ophthalmic complications in cystinosis","volume":"Xxx","author":"Buchan","year":"2010","journal-title":"International Journal of Pharmaceutics"},{"issue":"2","key":"10.1016\/j.carbpol.2023.120717_bb0050","doi-asserted-by":"crossref","first-page":"E329","DOI":"10.1208\/pt060243","article-title":"Cyclodextrins in drug delivery: An updated review","volume":"6","author":"Challa","year":"2005","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.carbpol.2023.120717_bb0055","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1208\/s12248-016-9932-z","article-title":"Clinical, pharmacokinetic, and in vitro studies to support bioequivalence of ophthalmic drug products","volume":"18","author":"Choi","year":"2016","journal-title":"AAPS Journal"},{"issue":"December 2018","key":"10.1016\/j.carbpol.2023.120717_bb0060","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejps.2018.12.012","article-title":"Corneal-PAMPA: A novel, non-cell-based assay for prediction of corneal drug permeability","volume":"128","author":"Darg\u00f3","year":"2019","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.carbpol.2023.120717_bb0065","first-page":"1","article-title":"Polysaccharides in ocular drug delivery","volume":"12","author":"Dubashynskaya","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.carbpol.2023.120717_bb0120","author":"European Medicines Agency"},{"issue":"3","key":"10.1016\/j.carbpol.2023.120717_bb0075","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2165\/00003495-199447030-00009","article-title":"Hyaluronic acid: A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing","volume":"47","author":"Goa","year":"1994","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.carbpol.2023.120717_bb0080","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0169-409X(93)90016-W","article-title":"Treatment of diseases of the eye with mucoadhesive delivery systems","volume":"11","author":"Greaves","year":"1993","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"2","key":"10.1016\/j.carbpol.2023.120717_bb0085","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.drudis.2015.11.017","article-title":"Cyclodextrins in pharmaceutical formulations I: Structure and physicochemical properties, formation of complexes, and types of complex","volume":"21","author":"Jambhekar","year":"2016","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.carbpol.2023.120717_bb0090","first-page":"459","article-title":"Beta-cyclodextrins as vehicles in eye-drop formulations: An evaluation of their effects on rabbit corneal epithelium","volume":"7","author":"Jansen","year":"1990","journal-title":"Lens and Eye Toxic Research"},{"issue":"6","key":"10.1016\/j.carbpol.2023.120717_bb0095","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1345\/aph.1R757","article-title":"Nepafenac: An ophthalmic nonsteroidal antiinflammatory drug for pain after cataract surgery","volume":"47","author":"Jones","year":"2013","journal-title":"Annals of Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.carbpol.2023.120717_bb0100","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1185\/030079906X89775","article-title":"Ocular permeation and inhibition of retinal inflammation: An examination of data and expert opinion on the clinical utility of nepafenac","volume":"22","author":"Lindstrom","year":"2006","journal-title":"Current Medical Research and Opinion"},{"issue":"10","key":"10.1016\/j.carbpol.2023.120717_bb0105","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/jps.20992","article-title":"Effects of cyclodextrins on drug delivery through biological membranes","volume":"96","author":"Loftsson","year":"2007","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"4","key":"10.1016\/j.carbpol.2023.120717_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/nano10040709","article-title":"In vitro and ex vivo evaluation of nepafenac-based cyclodextrin microparticles for treatment of eye inflammation","volume":"10","author":"Lorenzo-Veiga","year":"2020","journal-title":"Nanomaterials"},{"issue":"2","key":"10.1016\/j.carbpol.2023.120717_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/ma12020229","article-title":"Nepafenac-loaded cyclodextrin\/polymer nanoaggregates: A new approach to eye drop formulation","volume":"12","author":"Lorenzo-Veiga","year":"2019","journal-title":"Materials"},{"issue":"2","key":"10.1016\/j.carbpol.2023.120717_bb0125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1089\/jop.2012.0241","article-title":"Anterior eye segment drug delivery systems: Current treatments and future challenges","volume":"29","author":"Molokhia","year":"2013","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/j.carbpol.2023.120717_bb0130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/bcpt.12917","article-title":"Cyclodextrin-based formulations: A non-invasive platform for targeted drug delivery","volume":"122","author":"Muankaew","year":"2018","journal-title":"Basic and Clinical Pharmacology and Toxicology"},{"key":"10.1016\/j.carbpol.2023.120717_bb0135","unstructured":"GraphPad Prism, n.d.GraphPad Prism, version: 7.03; https:\/\/www.graphpad.com\/scientific-software\/prism\/. Accessed: Aug 29, 2022. (n.d.). GraphPad Software, Inc."},{"issue":"6","key":"10.1016\/j.carbpol.2023.120717_bb0140","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1208\/s12249-018-1094-0","article-title":"Improved ocular delivery of nepafenac by cyclodextrin complexation","volume":"19","author":"Shelley","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"12","key":"10.1016\/j.carbpol.2023.120717_bb0145","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1016\/j.xphs.2018.08.013","article-title":"In situ gel formulation for enhanced ocular delivery of nepafenac","volume":"107","author":"Shelley","year":"2018","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"3","key":"10.1016\/j.carbpol.2023.120717_bb0150","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/oxfordjournals.jbchem.a130935","article-title":"Viscosity and molecular weight of hyaluronic acids","volume":"78","author":"Shimada","year":"1975","journal-title":"Journal of Biochemistry"},{"key":"10.1016\/j.carbpol.2023.120717_bb0155","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3390\/polym12081800","article-title":"Hyaluronic acid: The influence of molecular weight and degradable properties of biopolymer","volume":"12","author":"Snetkov","year":"2020","journal-title":"Polymers"},{"key":"10.1016\/j.carbpol.2023.120717_bb0160","unstructured":"TIBCO\/Statistica, n.d.TIBCO\/Statistica, version: 13.5.017; https:\/\/www.statistica.com\/en\/software\/tibco-data-science-\/-tibco-statistica. Accessed: Aug 29. 2022. (n.d.)."},{"issue":"11","key":"10.1016\/j.carbpol.2023.120717_bb0165","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"9","key":"10.1016\/j.carbpol.2023.120717_bb0170","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jcrs.2007.05.015","article-title":"In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac","volume":"33","author":"Walters","year":"2007","journal-title":"Journal of Cataract and Refractive Surgery"},{"key":"10.1016\/j.carbpol.2023.120717_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121012","article-title":"Progress in drug formulation design and delivery of medicinal substances used in ophthalmology","volume":"607","author":"Wr\u00f3blewska","year":"2021","journal-title":"International Journal of Pharmaceutics"},{"issue":"January","key":"10.1016\/j.carbpol.2023.120717_bb0180","article-title":"Hyaluronic acid in ocular drug delivery","volume":"264","author":"Zhang","year":"2021","journal-title":"Carbohydrate Polymers"}],"container-title":["Carbohydrate Polymers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0144861723001819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0144861723001819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:41:11Z","timestamp":1758933671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0144861723001819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":35,"alternative-id":["S0144861723001819"],"URL":"https:\/\/doi.org\/10.1016\/j.carbpol.2023.120717","relation":{},"ISSN":["0144-8617"],"issn-type":[{"value":"0144-8617","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclodextrin-enabled nepafenac eye drops with improved absorption open a new therapeutic window","name":"articletitle","label":"Article Title"},{"value":"Carbohydrate Polymers","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carbpol.2023.120717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"120717"}}